- ￥6387
- BioLegend-HK
- 352931
- 美国
- 2025年07月12日
- 免疫荧光，流式
- 小鼠
- 人
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
TotalSeq™-C0132 anti-human EGFR
- 抗体英文名：
TotalSeq™-C0132 anti-human EGFR
- 浓度：
0.5 mg/mL
- 应用范围：
免疫荧光，流式
- 宿主：
小鼠
- 供应商：
上海善然生物
- 库存：
4-5周
- 抗原来源：
小鼠
- 保质期：
2-3年左右
- 适应物种：
人
- 标记物：
TotalSeq™-C0132
- 克隆性：
单克隆
- 保存条件：
2-8度
- 形态：
液体
- 规格：
10 μg
TotalSeq™-C0132 anti-human EGFR Antibody
AY13
GCTTAACATTGGCAC
Catalog# / Size 352931 / 10 µg
Clone
Regulatory Status RUO
Other Names Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, HER1
Isotype Mouse IgG1, κ
Barcode Sequence
Description Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein and member of
the protein kinase superfamily that regulates cell growth and differentiation. EGFR binds
EGF, TGF-α, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30, and
vaccinia virus growth factor - all members of the EGF family. Ligand binding induces EGFR
dimerization and autophosphorylation, initiating the MAPK, Akt, and JNK signaling
pathways. EGFR is expressed by epithelial and endothelial cells and is frequently
expressed by epithelial carcinomas.
Product Details
Verified Reactivity Human
Antibody Type Monoclonal
Host Species Mouse
Immunogen Non-small cell lung cancer (NSCLC) cell line NCI-H322
Formulation Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
Preparation The antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer
under optimal conditions.
Concentration 0.5 mg/mL
Storage & Handling The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验更多产品详细信息欢迎来电咨询~周祥15900853496微信同号，汪海洋15901695283微信同号
EGFR and Tumor Suppressor Function in Brain Cancer Development
of a conditional firefly luciferase transgene provides a means to monitor tumor initiation and growth noninvasively by bioluminescence imaging. The tumors that are generated in this model share numerous histopathological features with human GBMs. We provide
The EGFR Pathway as an Example for Genotype: Phenotype Correlation in Tumor Genes
to be determinants of response to new drugs that inhibit EGFR. We describe the correlation between the EGFR genotype, including the KRAS mutation, and the consequences of the resulting genotype for anti-EGFR therapy in colorectal cancer.
In Vivo Imaging of the Dynamics of Different Variants of EGFR in Glioblastomas
with the fusion of a bioluminescent–fluorescent marker. This unit describes a protocol for simultaneously imaging EGFR activity and progression of GBM in a mouse model. Human glioma cells transduced with lentiviral vectors bearing different combinations
技术资料暂无技术资料 索取技术资料
